Could hepatitis e be hiding in transplant patients? a screening study aims to find out.
NCT ID NCT07729202
First seen Jul 27, 2026 · Last updated Jul 28, 2026 · Updated 1 time
Summary
Hepatitis E can cause severe liver problems in people who have had an organ transplant, and may become chronic. This study screens liver and kidney transplant patients in Guadeloupe using blood tests to measure how many carry the virus. The goal is to learn whether routine screening should be adopted for this at-risk group.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If hepatitis E is found to be common in transplant patients in Guadeloupe, it could lead to routine screening and better monitoring to prevent chronic infection.
- What could go wrong
- This is a small, observational screening study in one region, so results may not apply elsewhere. It does not test any treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATITIS E are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre Hospitalier Universitaire de la Guadeloupe
Les Abymes, Guadeloupe, 97159, Guadeloupe
More trials for these conditions
Other studies related to the condition(s) this trial covers.